Conducting medical product clinical trials during the COVID-19 public health emergency presents unprecedented challenges. In light of the challenges presented by COVID-19, the Food and Drug Administration (FDA) issued...more
8/5/2020
/ Clinical Trials ,
Compliance ,
Coronavirus/COVID-19 ,
Food and Drug Administration (FDA) ,
Informed Consent ,
New Guidance ,
Public Health Emergency ,
Regulatory Requirements ,
Safety Precautions ,
Social Distancing ,
Vaccinations